Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Myeloproliferative neoplasms (MPNs) originate from genetically transformed hematopoietic stem cells that retain the capacity for multilineage differentiation and effective myelopoiesis. Beginning in early 2005, a number of novel mutations involving Janus kinase 2 (JAK2), Myeloproliferative Leukemia...

Descripción completa

Detalles Bibliográficos
Autor principal: Tefferi, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035972/
https://www.ncbi.nlm.nih.gov/pubmed/20428194
http://dx.doi.org/10.1038/leu.2010.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035972/
https://www.ncbi.nlm.nih.gov/pubmed/20428194
http://dx.doi.org/10.1038/leu.2010.69

Ejemplares similares